I’m glad to see that Meg Whitman is making some changes and I think this is a good start. There is no doubt that HPQ has been underinvested in R&D and I think it is crucial for them to make the long term decision to focus on innovation. With the stock trading at 6 times 2012 earnings, HPQ should buy back stock and stay away from any major acquisitions.
INVESTING IN THE FINANCIAL MARKETS INVOLVES RISKS. OPTIONS ARE NOT SUITABLE FOR ALL INVESTORS.